• Establishment Labs’ third-quarter 2026 net loss narrowed to $10.71 million.
• Revenue climbed 34% to $72 million, while U.S. revenue more than doubled to $26 million.
• Operating cash flow turned positive at $7.7 million, marking its first positive quarter.
• The U.S. commercial footprint expanded to more than 2,100 accounts, with more than 400 plastic surgeons trained on Preservé.
• Full-year 2026 revenue guidance rose to more than $274 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610290800BIZWIRE_USPR_____20261029_BW198419) on October 29, 2026, and is solely responsible for the information contained therein.